These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone. Shayeganpour A; Hamdy DA; Brocks DR Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of intravenous amiodarone in patients with refractory ventricular tachycardia/fibrillation. Korth-Bradley JM; Rose GM; de Vane PJ; Peters J; Chiang ST J Clin Pharmacol; 1996 Aug; 36(8):715-9. PubMed ID: 8877675 [TBL] [Abstract][Full Text] [Related]
4. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure. Candinas R; Frielingsdorf J; Ha HR; Carrel T; Turina M; Follath F Eur J Clin Pharmacol; 1998 Jan; 53(5):331-6. PubMed ID: 9516032 [TBL] [Abstract][Full Text] [Related]
5. Disposition of intravenous amiodarone in subjects with normal and impaired renal function. Ujhelyi MR; Klamerus KJ; Vadiei K; O'Rangers E; Izard M; Neefe DL; Zimmerman JJ; Chow MS J Clin Pharmacol; 1996 Feb; 36(2):122-30. PubMed ID: 8852388 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of intravenous amiodarone and comparison with two-stage pharmacokinetic analysis. Vadiei K; Troy S; Korth-Bradley J; Chiang ST; Zimmerman JJ J Clin Pharmacol; 1997 Jul; 37(7):610-7. PubMed ID: 9243354 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction. Tisdale JE; Overholser BR; Sowinski KM; Wroblewski HA; Amankwa K; Borzak S; Kingery JR; Coram R; Zipes DP; Flockhart DA; Kovacs RJ Pharmacotherapy; 2008 Dec; 28(12):1461-70. PubMed ID: 19025427 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects. Shiga T; Tanaka T; Irie S; Hagiwara N; Kasanuki H Heart Vessels; 2011 May; 26(3):274-81. PubMed ID: 21052689 [TBL] [Abstract][Full Text] [Related]
9. Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats. Morvay N; Baczkó I; Sztojkov-Ivanov A; Falkay G; Papp JG; Varró A; Leprán I Can J Physiol Pharmacol; 2015 Sep; 93(9):773-7. PubMed ID: 26176275 [TBL] [Abstract][Full Text] [Related]
10. A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data. Lu JT; Cai Y; Chen F; Jia WW; Hu ZY; Zhao YS Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):689-703. PubMed ID: 26254911 [TBL] [Abstract][Full Text] [Related]
11. Amiodarone concentration in human myocardium after rapid intravenous administration. Anastasiou-Nana MI; Nanas JN; Alexopoulos G; Karli JN; Margari ZJ; Agapitos E; Patsi EN; Stamatelopoulos SF Cardiovasc Drugs Ther; 1999 May; 13(3):265-70. PubMed ID: 10439890 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses. De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population. Kashima A; Funahashi M; Fukumoto K; Komamura K; Kamakura S; Kitakaze M; Ueno K Biol Pharm Bull; 2005 Oct; 28(10):1934-8. PubMed ID: 16204949 [TBL] [Abstract][Full Text] [Related]
15. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Massie BM; Fisher SG; Radford M; Deedwania PC; Singh BN; Fletcher RD; Singh SN Circulation; 1996 Jun; 93(12):2128-34. PubMed ID: 8925581 [TBL] [Abstract][Full Text] [Related]
17. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use. Chow MS Ann Pharmacother; 1996 Jun; 30(6):637-43. PubMed ID: 8792951 [TBL] [Abstract][Full Text] [Related]
18. Effects of orlistat, a lipase inhibitor, on the pharmacokinetics of three highly lipophilic drugs (amiodarone, fluoxetine, and simvastatin) in healthy volunteers. Zhi J; Moore R; Kanitra L; Mulligan TE J Clin Pharmacol; 2003 Apr; 43(4):428-35. PubMed ID: 12723464 [TBL] [Abstract][Full Text] [Related]
20. Intravenous amiodarone for therapy of atrial fibrillation and flutter in critically ill patients with severely depressed left ventricular function. Kumar A South Med J; 1996 Aug; 89(8):779-85. PubMed ID: 8701376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]